Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides

Britt-Marie Swahn1, Istvan Macsari, Jenny Viklund

  • 1Department of Medicinal Chemistry, AstraZeneca R&D Södertälje, S-151 85 Södertälje, Sweden. britt-marie.swahn@astrazeneca.com

Related Concept Videos